Glaucoma Treatment Market: North America to Remain Leading Revenue Contributor to Global Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Glaucoma is considered to be the second most cause for blindness around the world, according to WHO. This leading reason for preventable blindness is associated with chronic progressive optic neuropathy, which leads to irreversible vision loss via damage to optic nerve. No treatments currently exist for directly preventing glaucoma, however several commercially available therapies concentrate on curtailing elevated intraocular pressure, which is a known risk factor responsible for the development and progression of glaucoma.

Read Report Overview -

Glaucoma Treatment Market to Enter a New Phase of Expansion

Demand for glaucoma treatment is expected to be significantly driven by the advent of fixed-dose combination products that combine drugs from various classes. The market for glaucoma treatment will enter a new phase of expansion, with the introduction of first-in-class, innovative drugs such as trabodenoson, Vesneo, and Roclatan/Rhopressa. Prevalence of glaucoma is increasing in parallel with the rise in geriatric population worldwide, as older individuals are relatively more prone to developing glaucoma. In addition, mounting number of people with diabetes and those with family history of glaucoma also contribute to this disease prevalence significantly. Governments and healthcare institutions are increasingly taking initiatives to spread the awareness about treatment options available for patients with glaucoma.

Product development strategies in the recent past have been impressive with surgery options, with several effective additions such as photodynamic therapy and laser therapy. However, excellent efficiency and efficacy of currently available drugs, particularly carbonic anhydrase inhibitors and prostaglandin analogs, have set barriers to the development of new therapy options.

Request Brochure of Report -

A new exhaustive report collated by Transparency Market Research envisages an average growth for the global glaucoma treatment market in the period between 2017 and 2026.More than US$ 3,300 revenues are expected to be gained from treatment of glaucoma across the globe by 2026-end.

North America to Remain Leading Revenue Contributor to Global Glaucoma Treatment Market

Incidences of glaucoma in North American countries are rising significantly, with the surge in older population in the region, thereby creating high demand for glaucoma drugs. Demand for glaucoma drugs in the region is fulfilled owing to the presence of several pharmaceutical giants and heavy investments in pharmaceutical sector. In addition, the economic vigour and enormous investments in healthcare sector in North America have meant that the region will remain the leading revenue contributor to the global glaucoma treatment market. Europe and Asia-Pacific excluding Japan (APEJ) are also expected to be major revenue contributors to the market during the forecast period.

Prostaglandin analogs (PGAs) seek extensive adoption for treating OAG, owing to their relatively higher effectiveness. Among several types of prostaglandin analogs introduced in the market, administration of latanoprost, travoprost, and tafluprost has represented a comparatively more significant IOP-lowering ability in clinical trials. All these factors have made prostaglandin analogs to be highly sought-after among products available for glaucoma treatment. Alpha agonist will also prevail as a remunerative product in the glaucoma treatment market.

Request Sample of Report -

Key Research Findings from the Report

Hospital pharmacies will remain dominant among sales channels in the glaucoma treatment market

Angle closure glaucoma (ACG) are expected to be the most prevalent indication of glaucoma in the market during 2017 to 2026

Competition Tracking

The global market for glaucoma treatment is crowded with branded drugs coupled with surging number of generics, which in turn is creating significant competition in the market. This has further set limits to introduction of novel therapies, along with several products being due to lose exclusivity. Late-stage pipeline for glaucoma, however, holds promise for treatments imparting novel mechanisms of action, thereby creating lucrative growth opportunities for the market players. Key players underpinning growth of the global glaucoma treatment market include Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer, Santen, Aerie Pharmaceuticals, and Inotek Pharmaceuticals.

Get COVID-19 Analysis on Glaucoma Treatment Market -

Increasing Demand for Efficient Prescription Eye Drops Drive Glaucoma Treatment Market

Manufacturers and players in the glaucoma treatment market are focused on developing newer drug combinations and prescription eye drops to control glaucoma at a primary stage. Multiple bio-medical and pharmaceutical companies are investing in product development to develop effective drugs that can relieve the burden on healthcare facilities.

Some of the drugs used for treatment of glaucoma include prostaglandin analogs or PGAs, beta blockers, carbonic anhydrase inhibitors, alpha agonists, and cholinergic, as well as certain types of combination medicines. These drugs help in lowering the intraocular pressure by increasing the drainage of fluid from the patient’s eye. However, instances of drug recall by major industry players can hamper the growth of global glaucoma treatment market in coming years. Failure to meet the regulatory standards and noticeable impurities in various drug combinations are key factors behind these product recalls. Failure to meet regulatory standards is noticed to generate fear and skepticism in both patients and healthcare professionals.

Alternative techniques that require little medication and offer prolonged relief can promise potential growth in glaucoma treatment market in coming years. Some of the alternative techniques used for treatment of glaucoma include laser treatment known as selective laser trabeculoplasty and minimally invasive glaucoma surgeries, also known as MIGs. Both of these techniques also aim at reducing the intraocular pressure by stimulating an increased fluid outflow from the patient’s eye. However, the global pandemic caused by the outbreak of novel coronavirus has caused a slowdown in patients opting for SLTs and MIGs.

Make an Enquiry Before Buying -

As many countries have categorized glaucoma as ‘elective’, patients are preferring using medications and prescription eye drops to slow down the progression of glaucoma. Many patients are postponing their elective glaucoma surgeries for the time being and in turn, looking for newer and advanced medication solutions for the treatment of glaucoma. This trend is anticipated to boost the glaucoma treatment market in near future.

Market Taxonomy

A segmentation analysis delivered in the report submits insights on the global market for glaucoma treatment. The market is characterized based on sales channel, indication, product type, and region. Analyses on the Y-o-Y growth comparison, market share comparison, and the revenue comparison in accordance with relevant market numbers has been delivered in this chapter. The global market for glaucoma treatment has been divided regionally into Asia-Pacific excluding Japan, Europe, Middle East & Africa, Japan, Latin America, and North America.

More Trending Reports by Transparency Market Research –

Telehealth Market: Telehealth Market (Component: Hardware, Software, and Services; Application: Radiology, Cardiology, Urgent Care, Remote ICU, Psychiatry, Dermatology, and Others; and End-user: Payers, Providers, Patients, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Medical Device Technologies Market: Medical Device Technologies Market (Device Type: Cardiology Devices, Diagnostic Imaging Devices, Orthopedic Devices, Ophthalmology Devices, Endoscopy Devices, Diabetes Care Devices, Wound Management Devices, Kidney/Dialysis Devices, Anesthesia & Respiratory Care Devices, and Others; and End-user: Academics & Research, Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Animal Healthcare Market: Animal Healthcare Market (Product Type: Pharmaceuticals, Feed Additives, and Vaccines; and Animal Type: Companion Animals and Production Animals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Erectile Dysfunction Drugs Market: Erectile Dysfunction (ED) Drugs Market (Drug: Viagra, Cialis, Staxyn/Levitra, Stendra/Spedra, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Regulatory Affairs Outsourcing Market: Regulatory Affairs Outsourcing Market (Service: Regulatory Affairs, Clinical Trial Applications & Product Registrations, Regulatory Writing & Publishing, Regulatory Consulting & Legal Representation, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Digital Health Market: Digital Health Market (Product Type: Healthcare Information Systems and Wearable Devices; Component: Hardware, Software, and Services; and End-user: B2C and B2B) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Equine Healthcare Market: Equine Healthcare Market (Product Type: Drugs, Vaccines, and Medical Supplemental Feed; Disease Type: West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus, Equine Influenza, Equine Herpes Virus, Equine Encephalomyelitis and Others; and Distribution Channel: Veterinary Hospitals & Clinics, Retail Pharmacies & Drug Stores, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Stem Cells Market: Stem Cells Market (Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Others; Source: Autologous and Allogenic; Application: Regenerative Medicines and Drug Discovery & Development; and End-user: Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, and Service Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -


Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Back to news